Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance.
- NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_assertion description "[A proportion of Alzheimer's disease (AD) patients treated for several months with cholinesterase (ChE) inhibitors have shown some favorable response on cognition, but the characteristics of the responders are still unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance.
- NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_assertion evidence source_evidence_literature NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance.
- NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_assertion SIO_000772 11125238 NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance.
- NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_assertion wasDerivedFrom befree-20140225 NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance.
- NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_assertion wasGeneratedBy ECO_0000203 NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance.
- befree-20140225 importedOn "2014-02-25" NP184543.RAQuzeXqwR1ETLyv1fEmao6VrqeBZFWHvyhQu9ayWZa4I130_provenance.